{"id":68757,"date":"2026-06-23T23:38:44","date_gmt":"2026-06-23T15:38:44","guid":{"rendered":"https:\/\/flcube.com\/?p=68757"},"modified":"2026-06-23T23:38:45","modified_gmt":"2026-06-23T15:38:45","slug":"anhui-province-launches-national-alliance-for-monoclonal-antibody-biologics-volume-based-procurement","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=68757","title":{"rendered":"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The <strong>Anhui Provincial Healthcare Security Administration<\/strong> has formally invited other provinces to participate in a <strong>national biologics alliance volume-based procurement (VBP)<\/strong> specifically targeting <strong>monoclonal antibody drugs<\/strong>, with responses due by <strong>June 26, 2026<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-regulatory-framework-amp-timeline\" class=\"wp-block-heading\">Regulatory Framework &amp; Timeline<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Lead Authority<\/strong><\/td><td>Anhui Provincial Healthcare Security Administration<\/td><\/tr><tr><td><strong>Oversight Body<\/strong><\/td><td>National Healthcare Security Administration (NHSA)<\/td><\/tr><tr><td><strong>Initiative Start<\/strong><\/td><td>Research and preparation began in 2024<\/td><\/tr><tr><td><strong>Response Deadline<\/strong><\/td><td>June 26, 2026<\/td><\/tr><tr><td><strong>Procurement Type<\/strong><\/td><td>National alliance volume-based procurement (VBP)<\/td><\/tr><tr><td><strong>Target Category<\/strong><\/td><td>Monoclonal antibody biologics<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-market-readiness-assessment\" class=\"wp-block-heading\">Market Readiness Assessment<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Product Approvals:<\/strong> Over 100 monoclonal antibody products (including reference drugs and biosimilars) have received regulatory approval in China<\/li>\n\n\n\n<li><strong>Clinical History:<\/strong> Earliest monoclonal antibodies introduced in China have accumulated more than 20 years of clinical usage data<\/li>\n\n\n\n<li><strong>Supply Structure:<\/strong> Increasingly diversified manufacturer base with mature clinical protocols<\/li>\n\n\n\n<li><strong>Consensus Building:<\/strong> Extensive industry consultation completed with broad stakeholder agreement<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-current-drug-list-for-procurement\" class=\"wp-block-heading\">Current Drug List for Procurement<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Following the August 1, 2025 information collection notice from the Anhui Provincial Medical Procurement Center, the current circulating procurement list includes seven monoclonal antibody drugs:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Adalimumab<\/li>\n\n\n\n<li>Bevacizumab<\/li>\n\n\n\n<li>Denosumab<\/li>\n\n\n\n<li>Rituximab<\/li>\n\n\n\n<li>Trastuzumab<\/li>\n\n\n\n<li>Tocilizumab<\/li>\n\n\n\n<li>Infliximab<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Note: Pertuzumab was included in earlier drafts but has been excluded from the final candidate list.<\/em><\/p>\n\n\n\n<h2 id=\"h-strategic-implications\" class=\"wp-block-heading\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Impact:<\/strong> This national alliance approach represents a significant evolution from provincial-level procurement toward standardized nationwide pricing for high-value biologics<\/li>\n\n\n\n<li><strong>Cost Containment:<\/strong> Expected to generate substantial savings for China&#8217;s healthcare system while maintaining quality standards<\/li>\n\n\n\n<li><strong>Industry Response:<\/strong> Manufacturers of the seven targeted monoclonal antibodies will need to prepare competitive pricing strategies ahead of the formal bidding process<\/li>\n\n\n\n<li><strong>Implementation Timeline:<\/strong> Following the June 26 response deadline, formal procurement procedures are expected to commence in Q3 2026<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding China&#8217;s healthcare procurement policies and market implications. Actual implementation may vary based on provincial participation rates, industry feedback, and evolving regulatory guidance.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Anhui Provincial Healthcare Security Administration has formally invited other provinces to participate in a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[4],"tags":[43,82],"class_list":["post-68757","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-biosimilars","tag-vbp-voluem-based-procurement"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Anhui Provincial Healthcare Security Administration has formally invited other provinces to participate in a national biologics alliance volume-based procurement (VBP) specifically targeting monoclonal antibody drugs, with responses due by June 26, 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=68757\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=68757\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-23T15:38:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-23T15:38:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68757#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68757\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement\",\"datePublished\":\"2026-06-23T15:38:44+00:00\",\"dateModified\":\"2026-06-23T15:38:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68757\"},\"wordCount\":303,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Biosimilars\",\"VBP (voluem-based procurement)\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=68757#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68757\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=68757\",\"name\":\"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-23T15:38:44+00:00\",\"dateModified\":\"2026-06-23T15:38:45+00:00\",\"description\":\"The Anhui Provincial Healthcare Security Administration has formally invited other provinces to participate in a national biologics alliance volume-based procurement (VBP) specifically targeting monoclonal antibody drugs, with responses due by June 26, 2026.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68757#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=68757\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=68757#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement - Insight, China&#039;s Pharmaceutical Industry","description":"The Anhui Provincial Healthcare Security Administration has formally invited other provinces to participate in a national biologics alliance volume-based procurement (VBP) specifically targeting monoclonal antibody drugs, with responses due by June 26, 2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=68757","og_locale":"en_US","og_type":"article","og_title":"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=68757","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-23T15:38:44+00:00","article_modified_time":"2026-06-23T15:38:45+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=68757#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=68757"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement","datePublished":"2026-06-23T15:38:44+00:00","dateModified":"2026-06-23T15:38:45+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=68757"},"wordCount":303,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Biosimilars","VBP (voluem-based procurement)"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=68757#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=68757","url":"https:\/\/flcube.com\/?p=68757","name":"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-23T15:38:44+00:00","dateModified":"2026-06-23T15:38:45+00:00","description":"The Anhui Provincial Healthcare Security Administration has formally invited other provinces to participate in a national biologics alliance volume-based procurement (VBP) specifically targeting monoclonal antibody drugs, with responses due by June 26, 2026.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=68757#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=68757"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=68757#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/68757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=68757"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/68757\/revisions"}],"predecessor-version":[{"id":68758,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/68757\/revisions\/68758"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=68757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=68757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=68757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}